Literature DB >> 7944339

Antibody synthesis induced by endogenous internal images.

P G Seferian1, L S Rodkey.   

Abstract

In this study, immunization with a vaccine consisting of multiple F(ab')2 fragments of affinity-purified antitetanus toxoid antibodies covalently bound to a carrier protein successfully induced antitetanus toxoid antibodies. Further studies showed that this vaccine preparation contained no biologically detectable tetanus antigen. The induced antitetanus antibody (Ab1') titer was higher than the titer of antibodies binding control antigens. The immunizing F(ab')2 preparation did not elicit a secondary antitetanus response from mice primed with tetanus toxoid and, hence, appeared free of tetanus epitopes. The specificity of Ab1' was established by absorption and inhibition with antigen. Immunization with antitetanus F(ab')2 (Ab1') fragments appears to have elicited naturally occurring autologous antitetanus toxoid antibody (Ab1') through an idiotypic pathway. As predicted by network theory, anti-idiotype (Ab2) and antitetanus (Ab1') cycled reciprocally. Clonotypic characterization of Ab1' using isoelectric focusing and affinity immunoblotting showed increases in Ab1' titer to be the result of increased synthesis by limited subsets of antitetanus toxoid B-cell clones and not increased synthesis by multiple clones, as is characteristic of antigen-driven Ab1 responses. Many Ab1 and Ab1' clonotypes had identical pIs, suggesting that they either share V region genes or are the product of the same B-cell clones. These findings indicate that immunization with polyclonal multivalent Ab1 preparations can trigger active synthesis of antibodies with the same specificity. The results provide further evidence for naturally occurring idiotypic cascades that could be exploited for studies of catalytic antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944339     DOI: 10.1007/bf02787936

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  34 in total

1.  Biological mimicry of antigenic stimulation: analysis of the in vivo antibody responses induced by monoclonal anti-idiotypic antibodies.

Authors:  J Y Huang; R E Ward; H Kohler
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

2.  Quantitative analyses of immune network components.

Authors:  M J Lacy; M A Dombrink-Kurtzman; E W Voss
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

3.  Idiotypic networks and their possible exploitation for manipulation of the immune response.

Authors:  I M Roitt; A Cooke; D K Male; F C Hay; G Guarnotta; P M Lydyard; L P de Carvalho; Y Thanavala; J Ivanyi
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

4.  Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies.

Authors:  J Urbain; M Wikler; J D Franssen; C Collignon
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

5.  Structural basis of stimulatory anti-idiotypic antibodies.

Authors:  H L Cheng; A K Sood; R E Ward; T Kieber-Emmons; H Kohler
Journal:  Mol Immunol       Date:  1988-01       Impact factor: 4.407

6.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

7.  A "network antigen" for human CD4. A murine monoclonal anti-idiotype to Leu-3a induces an anti-CD4 response in naive mice.

Authors:  D G Healey; L Dianda; P C Beverley
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

8.  Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits.

Authors:  P A Cazenave
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

9.  Regulation of natural antiallotype antibody responses by idiotype network-induced auto-antiidiotypic antibodies.

Authors:  L S Rodkey; F L Adler
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Antibodies to idiotypes of isologous immunoglobulins.

Authors:  N Sakato; H N Eisen
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.